Swedish Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Initiator Pharma

Market Cap: SEK 226.9m

A clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.

Camurus

Market Cap: SEK 34.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Devyser Diagnostics

Market Cap: SEK 1.8b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Diamyd Medical

Market Cap: SEK 1.3b

Develops precision medicine therapies for the treatment of autoimmune diabetes.

Swedish Orphan Biovitrum

Market Cap: SEK 93.6b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Saniona

Market Cap: SEK 1.3b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Annexin Pharmaceuticals

Market Cap: SEK 186.4m

A biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases.

AddLife

Market Cap: SEK 22.8b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Bonesupport Holding

Market Cap: SEK 17.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

BioArctic

Market Cap: SEK 16.7b

Develops biological drugs for patients with central nervous system disorders in Sweden.

SynAct Pharma

Market Cap: SEK 782.2m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Cinclus Pharma Holding

Market Cap: SEK 771.6m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

BICO Group

Market Cap: SEK 2.4b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Biosergen

Market Cap: SEK 128.7m

A biotech company, develops antifungal products.

MedCap

Market Cap: SEK 6.3b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Hamlet BioPharma

Market Cap: SEK 653.0m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

AcuCort

Market Cap: SEK 167.3m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Vicore Pharma Holding

Market Cap: SEK 1.8b

A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.

Xintela

Market Cap: SEK 296.3m

A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.

Newbury Pharmaceuticals

Market Cap: SEK 84.8m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Sprint Bioscience

Market Cap: SEK 54.0m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Scandion Oncology

Market Cap: SEK 3.2m

A clinical-stage biotechnology company, develops medicines for the treatment of cancer.

Curasight

Market Cap: DKK 110.1m

A biotech company, develops treatment of cancer.

Xspray Pharma

Market Cap: SEK 1.5b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Ascelia Pharma

Market Cap: SEK 489.0m

A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.

Quia Pharma

Market Cap: SEK 7.7m

Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Double Bond Pharmaceutical International

Market Cap: SEK 11.8m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

Corline Biomedical

Market Cap: SEK 241.0m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Lipigon Pharmaceuticals

Market Cap: SEK 13.5m

Develops drugs for lipid related diseases in Sweden.

Nanologica

Market Cap: SEK 103.0m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Attana

Market Cap: SEK 29.0m

Attana AB provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

FluoGuide

Market Cap: SEK 531.2m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Karolinska Development

Market Cap: SEK 258.5m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.